RAFE Among Large Cap ETFs
End-of-day Nov 17, 2026 · 300 Large cap ETFs by 1M
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −1.6% | −2.5% | +0.1% | −0.6% | +20.4% | +24.0% | +77.6% | +68.6% | — | +127.8% |
| Peer average | −1.1% | −2.4% | −3.7% | −5.0% | +8.0% | +10.1% | +61.2% | +49.9% | +222.2% | — |
| S&P 500 · VOO | −1.0% | −2.4% | −4.5% | −4.5% | +8.3% | +10.2% | +72.7% | +68.0% | +305.1% | — |
$56 of every $1,000 in RAFE is Apple
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | AAPLApple 00001 | Technology | 5.64% | $564.14 | 28K | $10.0M |
| 2 | MSFTMicrosoft 00000625 | Technology | 5.18% | $517.64 | 18K | $9.2M |
| 3 | JNJJohnson + Johnson Usd1.0 | Healthcare | 3.13% | $313.18 | 20K | $5.6M |
| 4 | UNHUnitedhealth Group 01 | Healthcare | 2.85% | $285.07 | 12K | $5.1M |
| 5 | JPMJpmorgan Chase + Usd1.0 | Financial Services | 2.40% | $239.96 | 13K | $4.3M |
| 6 | PGProcter + Gamble /the | Consumer Defensive | 2.10% | $210.47 | 22K | $3.7M |
| 7 | MRKMerck + 5 | Healthcare | 2.08% | $208.48 | 26K | $3.7M |
| 8 | VZVerizon Communications 1 | Communication Services | 1.91% | $190.95 | 73K | $3.4M |
| 9 | ABBVAbbvie 01 | Healthcare | 1.81% | $180.76 | 11K | $3.2M |
| 10 | TAT+T USD1.0 | Communication Services | 1.66% | $166.13 | 132K | $3.0M |
| 11 | CCitigroup 01 | Financial Services | 1.41% | $141.48 | 21K | $2.5M |
| 12 | PFEPfizer 05 | Healthcare | 1.34% | $133.78 | 82K | $2.4M |
| 13 | MRNAModerna 0001 | Healthcare | 1.25% | $125.39 | 10K | $2.2M |
| 14 | BMYBristol Myers Squibb 1 | Healthcare | 1.14% | $113.78 | 32K | $2.0M |
| 15 | QCOMQualcomm 0001 | Technology | 1.12% | $112.32 | 12K | $2.0M |
of the $839B in 304 Large cap ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | AAPL | Apple 00001 | 5.64% |
| 2 | MSFT | Microsoft 00000625 | 5.18% |
| 3 | JNJ | Johnson + Johnson Usd1.0 | 3.13% |
| 4 | UNH | Unitedhealth Group 01 | 2.85% |
| 5 | JPM | Jpmorgan Chase + Usd1.0 | 2.40% |
| 6 | PG | Procter + Gamble /the | 2.10% |
| 7 | MRK | Merck + 5 | 2.08% |
| 8 | VZ | Verizon Communications 1 | 1.91% |
| 9 | ABBV | Abbvie 01 | 1.81% |
| 10 | T | AT+T USD1.0 | 1.66% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Oct 1, 2026 | Oct 5, 2026 | $0.19 |
| Jul 1, 2026 | Jul 6, 2026 | $0.19 |
| Apr 1, 2026 | Apr 3, 2026 | $0.19 |
| Dec 31, 2025 | Jan 5, 2026 | $0.17 |
| Oct 1, 2025 | Oct 3, 2025 | $0.17 |
| Jul 1, 2025 | Jul 3, 2025 | $0.18 |
| Apr 1, 2025 | Apr 3, 2025 | $0.18 |
| Dec 31, 2024 | Jan 3, 2025 | $0.17 |
| Oct 1, 2024 | Oct 3, 2024 | $0.15 |
| Jul 1, 2024 | Jul 3, 2024 | $0.16 |
| Apr 1, 2024 | Apr 4, 2024 | $0.17 |
| Dec 28, 2023 | Jan 3, 2024 | $0.16 |